Objective: Liver adenomatosis (LA) is a rare disease originally defined by Flejou et al in 1985 from a series of 13 cases. In 1998, 38 cases were available for analysis, including eight personal cases. The aim of this study was to review and reappraise the characteristics of this rare liver disease and to discuss diagnosis and therapeutic options.

Background: LA was defined as the presence of >10 adenomas in an otherwise normal parenchyma. Neither female predominance nor a relation with estrogen/progesterone intake has been noted. Natural progression is poorly known.

Methods: The clinical presentation, evolution, histologic characteristics, and therapeutic options and results were analyzed based on a personal series of eight new cases and an updated review of the literature.

Results: From a diagnostic standpoint, two forms of liver adenomatosis with different presentations and evolution can be defined: a massive form and a multifocal form. The role of estrogen and progesterone is reevaluated. The risks of hemorrhage and malignant transformation are of major concern. In the authors' series, liver transplantation was indicated in two young women with the massive, aggressive form, and good results were obtained.

Conclusion: Liver adenomatosis is a rare disease, more common in women, where outcome and evolution vary and are exacerbated by estrogen intake. Most often, conservative surgery is indicated. Liver transplantation is indicated only in highly symptomatic and aggressive forms of the disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420968PMC
http://dx.doi.org/10.1097/00000658-200001000-00011DOI Listing

Publication Analysis

Top Keywords

liver adenomatosis
16
adenomatosis rare
8
rare disease
8
series cases
8
liver transplantation
8
transplantation indicated
8
liver
7
cases
5
adenomatosis reappraisal
4
reappraisal diagnosis
4

Similar Publications

Article Synopsis
  • - Hepatocellular adenomas (HAs) are liver tumors linked to genetic mutations, with this study focusing on a 17-year-old with multiple HAs and a specific pathogenic mutation known to have a dominant negative effect.
  • - The study identified additional somatic variants in some HAs and revealed significant transcriptomic changes, including alterations in various metabolic pathways, angiogenesis, and immune response.
  • - Findings provide a detailed molecular profile of HAs associated with the identified mutation, paving the way for possible non-surgical treatment strategies by pinpointing new therapeutic targets.
View Article and Find Full Text PDF
Article Synopsis
  • Androgens are linked to causing liver tumors, both benign and malignant, such as hepatocellular adenoma and carcinoma, but the exact mechanisms are still unknown.
  • A case study of a 24-year-old male who developed an androgen-induced hepatocellular adenoma revealed symptoms like severe abdominal pain and a history of testosterone use, leading to significant complications.
  • The diagnosis involved imaging and biopsy, which confirmed atypical liver cells and highlighted the importance of considering androgen-induced liver tumors when diagnosing acute abdominal issues.
View Article and Find Full Text PDF

Liver Transplantation for Adenomatosis: A Single-Center Experience.

Transplant Proc

June 2024

Liver and Abdominal Organs Transplantation Division, Department of Gastroenterology, Hospital das Clínicas da Faculdade de Medicina de São Paulo (HC-FMUSP), São Paulo, Brazil; Laboratory of Medical Investigation 37 (LIM-37), Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, Brazil.

Background: Liver adenomatosis is characterized by multiple adenomas diffusely distributed throughout the liver parenchyma. Studies addressing liver transplantation for those cases are scarce, and the criteria used to indicate transplantation are still debatable.

Objective: To report a single-center experience of liver transplantation for diffuse adenomatosis.

View Article and Find Full Text PDF

Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature.

JHEP Rep

June 2024

Centre de recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.

Article Synopsis
  • Hepatocellular adenomas (HCAs) are uncommon, benign liver tumors that affect both children and adults differently, necessitating a specific analysis of pediatric cases.
  • A comprehensive study involving 316 children revealed that HCAs predominantly occur in girls around the age of 11.5, with a high prevalence linked to predisposing conditions such as glycogen storage disease, portosystemic shunts, and MODY3.
  • Notably, complications like bleeding and tumor transformation were common, with management strategies varying based on the underlying diseases and tumor characteristics, including potential surgical interventions like resections or liver transplants.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!